Job Search Results - Biospace
Get Our FREE Industry eNewsletter


Refine Job Search:

Clear All Selections
Selected Employer
AbbVie Stemcentrx
Location (8)
Employers (8)
Area of Expertise (0)
Posted Date (8)
Position Type (8)
Required Education (8)

Clear All Selections

Your search returned 8 jobs



6/22/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta™, and Empliciti™ — and a pipeline containing multiple promising new molecules that are being studied...

6/20/2017
AbbVie Stemcentrx
San Francisco, CA

Oncology is a keytherapeutic area for AbbVie, with a portfolio consisting of three marketedproducts — Imbruvica, Venclexta, and Empliciti — and a pipeline containingmultiple promising new molecules that are being studied in nearly 200...

6/8/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/8/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

5/23/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...